PLIANT THERAPEUTICS, INC. (PLRX) Net income 2019–2025
PLIANT THERAPEUTICS, INC. (PLRX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$149.3MFY2025 · since FY2019: -$631,000 → -$149.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$149.3M | +29.0% |
| FY2024 | -$210.3M | -30.4% |
| FY2023 | -$161.3M | -30.8% |
| FY2022 | -$123.3M | -26.8% |
| FY2021 | -$97.3M | -134.2% |
| FY2020 | -$41.5M | -6482.1% |
| FY2019 | -$631,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PLRX financial trends
PLRX RevenuePLRX Net marginPLRX Gross profitPLRX Gross marginPLRX Operating incomePLRX Operating marginPLRX Operating cash flowPLRX Free cash flowPLRX Capital expendituresPLRX Return on equityPLRX Stock buybacksPLRX Dividends paidPLRX Total assetsPLRX Total liabilitiesPLRX Shareholders’ equityPLRX overview →